Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination-Reference-Cited by-同舟云学术

Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination

Published:2022-10-21 Issue:43 Volume:94 Page:14835-14845
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Mu Ruipeng¹,Huang Yue¹^ORCID,Bouquet Jerome¹,Yuan Jiaqi¹,Kubiak Robert J.²,Ma Eric³,Naser Sami³,Mylott William R.³,Ismaiel Omnia A.³⁴^ORCID,Wheeler Aaron M.³,Burkart Rebecca³,Cortes Diego F.³,Bruton James³,Arends Rosalinda H.²,Liang Meina¹,Rosenbaum Anton I.¹^ORCID

Affiliation:

1. Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, South San Francisco, California 94080, United States

2. Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland 20878, United States

3. Research and Development Biologics by LC-MS/MS, PPD Laboratories, Richmond, Virginia 23230, United States

4. Faculty of Pharmacy, Zagazig University, Zagazig 2, Zagazig, Egypt

Funder

AstraZeneca

U.S. Department of Defense

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.2c01320

Reference47 articles.